Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-09 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |